By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer will sell, service, and provide support for Roche's NimbleGen CGX microarray workflow for most countries outside the US under a supply agreement deal announced today by the two companies.

Roche will continue to sell the workflow in the US and other select markets under the terms of the deal, which takes effect in January.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

NPR reports that with medical data being big business, some companies want to get patients involved.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.